Scott Tucci, OD
Optometrist · Wilmington, DENPI 1902883895
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.2% of the total across 63 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by Johnson & Johnson Vision Care, Inc. at 24.7% of the total. 2025 is the largest year on record at $847, 2.3 times the $375 reported in 2019. Among optometrist clinicians in DE with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 63 payments — averaging $47.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson Vision Care, Inc.$738
- Alcon$728
- Coopervision Inc.$464
- Bausch & Lomb Americas Inc.$429
- Ortho-clinical Diagnostics, Inc.$185
- Bausch & Lomb, A Division Of Bausch Health US, LLC$160
- plus $280 from 3 others
What the payments were for
- Speaking & faculty fees$2047%
- Food & beverage$2,78193%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson Vision Care, Inc. | 16 | $738 |
| Alcon | 24 | $728 |
| Coopervision Inc. | 9 | $464 |
| Bausch & Lomb Americas Inc. | 4 | $429 |
| Ortho-clinical Diagnostics, Inc. | 2 | $185 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 5 | $160 |
| Kala Pharmaceuticals, Inc. | 1 | $122 |
| Tarsus Pharmaceuticals, Inc. | 1 | $114 |
| Glaukos Corporation | 1 | $45 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Acuvue$352
- MIEBO$235
- XIIDRA$235
- Precision 1$234
- VYZULTA$225
- MiSight Contact Lens$204
- Clariti Contact Lens$136
- EYSUVIS$122
- TOTAL30$120
- XDEMVY$114
How this compares
$2,985 in reported general payments places this provider in the 95th percentile of 146 optometrist providers in Delaware.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 25 | $204 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Wilmington
- Jennifer TuranoWilmington$42K
- Laura GoldbergWilmington$17K
- Lea MenearWilmington$4K
- Lorna SimmermanWilmington$4K
- Alissa LongWilmington$4K
- Sarah Nowicki-DuczeminskiWilmington$3K
- Daniel BaruffiWilmington$2K
- Jamie WohlhagenWilmington$2K
- Leanne HeuerWilmington$2K
- Alex QuachWilmington$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.